Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs.
Bekliz M, Adea K, Vetter P, Eberhardt CS, Hosszu-Fellous K, Vu DL, Puhach O, Essaidi-Laziosi M, Waldvogel-Abramowski S, Stephan C, L'Huillier AG, Siegrist CA, Didierlaurent AM, Kaiser L, Meyer B, Eckerle I.
Bekliz M, et al. Among authors: essaidi laziosi m.
Nat Commun. 2022 Jul 4;13(1):3840. doi: 10.1038/s41467-022-31556-1.
Nat Commun. 2022.
PMID: 35787633
Free PMC article.